Mesothelioma and asbestos news
This page tracks major developments for people with mesothelioma and their families. We post only significant items, newest first, and each post links to the court record, agency notice, trust notice, or announcement it is based on.
In short
- We cover verdicts and court rulings, trust payment-percentage changes, EPA asbestos rules, FDA approvals and designations, major research, and NCI cancer-center designations.
- Dates shown are the date of the development and the date we posted it.
- Nothing here is legal or medical advice. Talk with your doctor about treatment news, and with a licensed attorney about legal news. Laws can change.
Latest
Owens-Illinois, Manville, and API asbestos trusts raise their payment percentages
August and September 2026 · posted October 29, 2026
O-I went from 50% to 65%, Manville from 5.1% to 5.6%, and API from 22% to 44%, per the trusts' own notices.
Two experimental mesothelioma drugs receive FDA orphan drug and fast track designations
April and July 2026 · posted October 29, 2026
ODM-212 (orphan drug, April 2026) and ISM6331 (fast track, July 2026). Both are still in trials; neither is approved.
EPA's chrysotile asbestos ban stays in effect while a federal appeals court weighs challenges
June 1, 2026 · posted October 29, 2026
The Fifth Circuit heard arguments on June 1, 2026; the 2024 rule remains in effect while the court decides.
NCI recognizes Mount Sinai's Tisch Cancer Institute and the Cancer Center at Illinois
September 2025 and April 2026 · posted October 29, 2026
Tisch (New York City) became Comprehensive in September 2025; Illinois became NCI's 74th center in April 2026.
Minnesota jury awards $65.5 million in a talc and mesothelioma case against Johnson & Johnson
December 19, 2025 · posted October 29, 2026
Ramsey County jury, December 2025. Johnson & Johnson disputes the claims and said it would appeal.
What we cover and how
We add an item when it changes something concrete for patients or families, such as money paid on trust claims, the legal status of asbestos, the treatments available, or where specialist care is offered. We do not cover routine filings, individual settlements without a public record, or advertising. If we get something wrong, we correct it and update the date on the post. See about this site for how we write and source pages.